Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?

@article{Crujeiras2017PlasmaFL,
  title={Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?},
  author={Ana B Crujeiras and Diego Gomez-Arbelaez and Maria Angeles Zulet and Marcos C Carreira and Ignacio Sajoux and Daniel Antonio de Luis and Adalberto Izquierdo Castro and Jm Baltar and Iv{\'a}n Baamonde and Antonio Sueiro and Manuel Mac{\'i}as-Gonz{\'a}lez and Diego Garrido Bellido and Francisco J Tinahones and Jos{\'e} Antonio Mart{\'i}nez and Felipe F Casanueva},
  journal={International Journal of Obesity},
  year={2017},
  volume={41},
  pages={1570-1578}
}
Background:Fibroblast growth factor 21 (FGF21) has been suggested to be an endocrine signal of nutritional status and an active regulator of metabolism. However, there is no agreement on the effect of weight-loss therapies on circulating levels of FGF21 in humans.Objective:To assess FGF21 circulating levels in adiposity excess and after different weight-loss strategies prescribed in five different groups from four independent centers.Subjects and methods:Body composition, ketosis, insulin… CONTINUE READING
21
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 67 REFERENCES